Xistab 1.5mg 100 tablets

Xistab is a non-prescription medication and is indicated for smoking cessation and reducing the desire for nicotine in smokers willing to stop smoking. Its use allows a gradual reduction in nicotine dependence and the loss of the smoking habit, relieving withdrawal symptoms. The goal of treatment is the permanent cessation of use of nicotine-containing products.

Active substance: each tablet contains 1.5mg of cytisinicline.

Contraindications:

Hypersensitivity to the active substance or to any of the excipients. Unstable angina. Recent history of myocardial infarction. Clinically significant arrhythmias. History of recent stroke. Pregnancy and breastfeeding.

Dosage and method of administration:

One box of Xistab (100 tablets) is enough for a complete treatment. The duration of treatment is 25 days.

Tobacco consumption must be stopped no later than the 5th day of treatment. Tobacco consumption should not be continued during treatment, as it may worsen adverse reactions. In case of treatment failure, treatment should be discontinued and may be resumed after 2 to 3 months.

If you have any doubts or symptoms persist, consult your doctor or pharmacist.

According to current legislation, medicines not subject to medical prescription, in Portugal, can only be delivered in the municipalities of Maia, Gondomar, Matosinhos, Porto, Santo Tirso, Trofa, Valongo and Vila do Conde. This limitation does not apply to shipments to other Member States of the European Union.